NasdaqGS - Nasdaq Real Time Price USD
Dyne Therapeutics, Inc. (DYN)
11.76
-0.58
(-4.70%)
At close: May 21 at 4:00:01 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BESKROVNAYA OXANA Officer | Sale | Mar 11, 2025 | 195,840 |
COX JOHN Chief Executive Officer | Sale | Mar 5, 2025 | 178,239 |
FRIEDL-NADERER JOHANNA Officer | Sale | Mar 13, 2025 | 96,057 |
HIGH SUSANNA GATTI Chief Operating Officer | Sale | Sep 18, 2024 | 131,636 |
INCERTI CARLO Director | Sale | Nov 18, 2024 | 0 |
KERR DOUGLAS Officer | Sale | Mar 5, 2025 | 94,157 |
KERSTEN DIRK Director | Sale | Dec 9, 2024 | -- |
LUCERA ERICK J. Chief Financial Officer | Stock Award(Grant) | Mar 31, 2025 | 66,100 |
RHODES JASON P Director | Stock Award(Grant) | Jan 27, 2025 | -- |
SCALZO RICHARD WILLIAM Officer | Sale | Mar 11, 2025 | 122,330 |
Related Tickers
RNA Avidity Biosciences, Inc.
30.62
-3.22%
BCAX Bicara Therapeutics Inc.
14.59
-2.99%
SION Sionna Therapeutics, Inc.
13.50
-3.64%
SRRK Scholar Rock Holding Corporation
30.72
-2.60%
ETNB 89bio, Inc.
9.61
+6.42%
ELVN Enliven Therapeutics, Inc.
16.93
-2.59%
RVMD Revolution Medicines, Inc.
38.74
-4.27%
EWTX Edgewise Therapeutics, Inc.
14.59
-1.88%
KURA Kura Oncology, Inc.
6.20
-2.82%
SLN Silence Therapeutics plc
5.14
0.00%